Antibody escape, the risk of serotype formation, and rapid immune waning: modeling the implications of SARS-CoV-2 immune evasion

Author:

Albright Catherine,Van Egeren DebraORCID,Thakur Aditya,Chakravarty ArijitORCID,White Laura F.ORCID,Stoddard MadisonORCID

Abstract

AbstractAs the COVID-19 pandemic progresses, widespread community transmission of SARS-CoV-2 has ushered in a volatile era of viral immune evasion rather than the much-heralded stability of “endemicity” or “herd immunity.” At this point, an array of viral variants has rendered essentially all monoclonal antibody therapeutics obsolete and strongly undermined the impact of vaccinal immunity on SARS-CoV-2 transmission. In this work, we demonstrate that antigenic drift resulting in evasion of pre-existing immunity is highly evolutionarily favored and likely to cause waves of short-term transmission. In the long-term, invading variants that induce weak cross-immunity against pre-existing strains may co-circulate with those pre-existing strains. This would result in the formation of serotypes that increase disease burden, complicate SARS-CoV-2 control and raise the potential for increases in viral virulence. Less durable immunity does not drive positive selection as a trait, but such strains may transmit at high levels if they establish. Overall, our results draw attention to the importance of inter-strain cross-immunity as a driver of transmission trends and the importance of early immune evasion data to predict the trajectory of the pandemic.

Publisher

Cold Spring Harbor Laboratory

Reference59 articles.

1. sPowell A. Anthony Fauci offers a timeline for ending COVID-19 pandemic. In: Harvard Gazette [Internet]. 10 Dec 2020 [cited 7 Oct 2022]. Available: https://news.harvard.edu/gazette/story/2020/12/anthony-fauci-offers-a-timeline-for-ending-covid-19-pandemic/

2. The covid-19 pandemic will be over by the end of 2021, says Bill Gates. The Economist. Available: https://www.economist.com/international/2020/08/18/the-covid-19-pandemic-will-be-over-by-the-end-of-2021-says-bill-gates. Accessed 22 Jan 2023.

3. Pence M. There Isn’t a Coronavirus ‘Second Wave.’ Wall Street Journal. 16 Jun 2020. Available: https://www.wsj.com/articles/there-isnt-a-coronavirus-second-wave-11592327890. Accessed 22 Jan 2023.

4. Pathways to COVID-19 ‘community protection’

5. Mathieu E , Ritchie H , Rodés-Guirao L , Appel C , Giattino C , Hasell J , et al. Coronavirus Pandemic (COVID-19). Our World in Data. 2020 [cited 22 Jan 2023]. Available: https://ourworldindata.org/covid-vaccinations

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3